Author

Matthew R. Blakiston

Observed names: Blakiston, Matthew, M. Blakiston, Matt Blakiston, Matthew Blakiston, Matthew R Blakiston

Observed institutions: The Royal Melbourne Hospital, The University of Melbourne, Liverpool School of Tropical Medicine, Auckland City Hospital, London School of Hygiene & Tropical Medicine, Palmerston North Hospital, Peter Doherty Institute, Counties Manukau District Health Board, Auckland District Health Board, Comer Children's Hospital, Atenisi Institute, MRC University of Glasgow Centre for Virus Research, Medlab Central (New Zealand), Institute of Infection and Immunity, Health New Zealand, MRC/UVRI & LSHTM Uganda Research Unit, University of Otago, Uganda Virus Research Institute

ORCID: 0000-0002-1344-057X

Observed ORCID: 0000-0002-1344-057X

OpenAlex ID: A5061543209

Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions

2023 · Patrick M Meyer Sauteur, Michael L Beeton, et al. · The Lancet Microbe · 324

PDF

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

2022 · Houriiyah Tegally, James E. San, et al. · Science · 192

PDF

Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study

2025 · Patrick M Meyer Sauteur, Xu-Sheng Zhang, et al. · The Lancet Microbe · 88

Mycoplasma pneumoniae: gone forever?

2023 · Patrick M Meyer Sauteur, Michael L Beeton, et al. · The Lancet Microbe · 85

PDF

Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?

2022 · Patrick M Meyer Sauteur, Victoria J Chalker, et al. · The Lancet Microbe · 79

PDF

Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae

2024 · Patrick M Meyer Sauteur, Michael L Beeton, et al. · The Lancet Microbe · 74

PDF

Diagnostic Performance of Pleural Fluid Adenosine Deaminase for Tuberculous Pleural Effusion in a Low-Incidence Setting

2018 · Matthew Blakiston, Weldon Chiu, et al. · Journal of Clinical Microbiology · 46

Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries

2015 · Saddiq T. Abdurrahman, Omezikam Mbanaso, et al. · Journal of Clinical Microbiology · 45

In sight, in mind: Retailer compliance with legislation on limiting retail tobacco displays

2008 · Megan Quedley, Brendan Ng, et al. · Nicotine & Tobacco Research · 38

SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study

2021 · Andrew Fox-Lewis, Shivani Fox-Lewis, et al. · Pathology · 23

PDF

Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide Therapy

2015 · Alice L. den Hertog, María Montero-Martín, et al. · PLoS ONE · 18

PDF

Nosocomial bacteriuria in elderly inpatients may be leading to considerable antibiotic overuse: an audit of current management practice in a secondary level care hospital in New Zealand

2014 · Matt Blakiston, Syed Zaman · Infection and Drug Resistance · 13

PDF

Hospital-Onset MRSA Bacteremia Rates Are Significantly Correlated With Sociodemographic Factors: A Step Toward Risk Adjustment

2018 · Joshua T. Freeman, Matthew R. Blakiston, et al. · Infection Control and Hospital Epidemiology · 11

Are patients with pulmonary tuberculosis who are identified through active case finding in the community different than those identified in healthcare facilities?

2016 · S.T. Abdurrahman, L. Lawson, et al. · New Microbes and New Infections · 10

The clear and present danger of carbapenemase-producing Enterobacteriaceae (CPE) in New Zealand: time for a national response plan

2019 · Blakiston, Matthew, Heffernan, Helen, et al. · PubMed · 8

Serratia Marcescens Endophthalmitis and Bacteraemia following Complicated Cataract Surgery

2021 · Riyaz Bhikoo, Matt Blakiston, et al. · Ocular Immunology and Inflammation · 7

Population-level exposures associated with MRSA and ESBL-E. coli infection across district health boards in Aotearoa New Zealand: an ecological study.

2020 · Matthew R Blakiston, Joshua T Freeman · PubMed · 7

Epidemiology of carbapenem resistant Acinetobacter baumannii in New Zealand

2022 · Sally Roberts, Matthew Blakiston, et al. · New Zealand Medical Journal · 6

PDF

Macrolide resistant Mycoplasma pneumoniae in Auckland, New Zealand

2022 · Matthew R. Blakiston, Anna Vesty, et al. · Pathology · 6

Evaluation of ssrA-targeted real time PCR for the detection of Bartonella species in human clinical samples and reflex sequencing for species-level identification

2022 · Anna Vesty, Gillian Henderson, et al. · Pathology · 6

Clinical alert: arrival of terbinafine resistant Trichophyton indotineae in New Zealand

2025 · Wendy McKinney, Matthew Blakiston, et al. · New Zealand Medical Journal · 5

PDF

Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort

2024 · Tim Cutfield, Soana Karuna Motuhifonua, et al. · PLoS neglected tropical diseases · 5

PDF

Characterisation of Neisseria gonorrhoeae strain differences in patients with multisite infection

2024 · Victoria F Miari, Matthew R Blakiston, et al. · Sexually Transmitted Infections · 4

PDF

Evaluating the sensitivity and specificity of dried blood spots for serological testing of HIV, syphilis, hepatitis B and C Elecsys assays on the Roche Cobas system

2023 · Gary McAuliffe, Adri Gerber, et al. · Pathology · 4

2020 · Aakash V Chhibber, Sharmini Muttaiyah, et al. · PubMed · 3

Works count: 34

Citation count: 1,117

H-index: 12

I10-index: 14